Secondary Logo

Journal Logo

November 2006 - Volume 16 - Issue 11
pp: 771-845


No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia

Riemann, Kathrin; Becker, Lucie; Struwe, Henrike; More

Pharmacogenetics and Genomics. 16(11):783-788, November 2006.

Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity

Carmo, Helena; Brulport, Marc; Hermes, Matthias; More

Pharmacogenetics and Genomics. 16(11):789-799, November 2006.

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics

Niemi, Mikko; Arnold, Katja A.; Backman, Janne T.; More

Pharmacogenetics and Genomics. 16(11):801-808, November 2006.

Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients

Amatori, Federica; Di Paolo, Antonello; Del Tacca, Mario; More

Pharmacogenetics and Genomics. 16(11):809-816, November 2006.

A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation

Terrazzino, Salvatore; Agostini, Marco; Pucciarelli, Salvatore; More

Pharmacogenetics and Genomics. 16(11):817-824, November 2006.

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

Motsinger, Alison A.; Ritchie, Marylyn D.; Shafer, Robert W.; More

Pharmacogenetics and Genomics. 16(11):837-845, November 2006.